Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin, Acetylcysteine and Danazol for Steroid-resistant/Relapsed ITP
NCT03460808Phase 2Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Mar 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin, acetylcysteine in immune thrombocytopenia (ITP), sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
atorvastatinacetylcysteine
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT03460808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03460808.